Dan Thomas's most recent trade in Concentra Group Holdings Parent Inc. was a trade of 6,496 Common Stock done . Disclosure was reported to the exchange on Nov. 26, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Concentra Group Holdings P... | Daniel Thomas J. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2024 | 6,496 | 59,796 | - | 0 | Common Stock | |
Concentra Group Holdings P... | Thomas J. Daniel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2024 | 6,496 | 66,252 | - | 0 | Common Stock | |
Concentra Group Holdings P... | Daniel J. Thomas | Director | Other type of transaction at price $ 0.00 per share. | 25 Nov 2024 | 53,260 | 53,260 | - | 0 | Common Stock | |
Gossamer Bio Inc | Thomas O. Daniel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 115,000 | 115,000 | - | - | Non-qualified stock option (Right to Buy) | |
Select Medical Holdings Co... | Daniel J. Thomas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2024 | 10,000 | 66,000 (0%) | 0% | 0 | Common Stock | |
Select Medical Holdings Co... | Daniel J. Thomas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2023 | 10,000 | 56,000 (0%) | 0% | 0 | Common Stock | |
Gossamer Bio Inc | Thomas O. Daniel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 35,000 | 35,000 | - | - | Stock Option (Right to Buy) | |
Select Medical Holdings Co... | Daniel J. Thomas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2022 | 10,000 | 46,000 (0%) | 0% | 0 | Common Stock | |
Gossamer Bio Inc | Thomas O. Daniel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
Select Medical Holdings Co... | Daniel J. Thomas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2021 | 6,000 | 36,000 (0%) | 0% | 0 | Common Stock | |
Gossamer Bio Inc | Thomas O. Daniel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2021 | 23,500 | 23,500 | - | - | Stock Option (Right to Buy) | |
Larimar Therapeutics Inc | Thomas O. Daniel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2021 | 8,300 | 8,300 | - | - | Stock Option (right to buy) | |
Larimar Therapeutics Inc | Thomas O. Daniel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Sep 2020 | 16,600 | 16,600 | - | - | Stock Option (right to buy) | |
Select Medical Holdings Co... | Daniel J. Thomas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jul 2020 | 10,000 | 30,000 (0%) | 0% | 0 | Common Stock | |
Gossamer Bio Inc | Thomas O. Daniel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2020 | 23,500 | 23,500 | - | - | Stock Option (right to buy) |